溶解性CD40L:急性冠動脈症候群後のリスク予測
Nerea Varo1, James A de Lemos, Peter Libby
1Donald W. Reynolds Cardiovascular Clinical Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA.
Circulation
|August 13, 2003
まとめ
溶解性CD40リガンド (sCD40L) レベルが上昇すると,急性冠動脈症候群の患者の再発性心臓事件が予測されます. sCD40Lと心臓トロポニンI (cTnI) を併用すると,死亡および心筋梗塞のリスク予測が著しく向上します.
科学分野:
- 心血管医学 心血管医学
- バイオマーカーの発見
- クリニカル・カーディオロジー 臨床心臓科
背景:
- 血溶性CD40リガンド (sCD40L) の上昇は,心血管疾患のリスクと関連しています.
- この研究では,sCD40Lが急性冠動脈症候群 (ACS) 患者の再発リスクの特定における役割を調査しました.
研究 の 目的:
- プラズマのsCD40Lが単独で,または心臓トロポニンI (cTnI) とC反応性タンパク質 (CRP) と併用して,再発性心臓イベントのリスクが高いACS患者さんを特定するかどうかをテストする.
- ACS.でsCD40Lの独立した予後値を評価する.
主な方法:
- OPUS-TIMI16試験における内蔵されたケース・コントロール研究.
- 10カ月以内に再発したACS症例 (死亡,心筋梗塞,心筋梗塞) を195例,195例の対照群と比較した.
- 血のsCD40L,cTnI,CRPレベルを測定した.
主要な成果:
- 再発的なイベントを有する患者は,sCD40Lの中央値 (0.78 ng/mL vs 0.52 ng/mL) が有意に高かった.
- sCD40L濃度の上昇は,独立して死亡,心筋梗塞,および複合エンドポイント (調整HRs 1.8-1.9) のリスクの高さを予測した.
- sCD40LとcTnIの併用増加は,死亡,心筋梗塞,または複合エンドポイント (調整HRs 4.3-12.1) のリスクの有意な増加を示した.
結論:
- 血のsCD40L値が上昇すると,cTnIとCRPとは無関係に,ACS患者の死亡リスクと再発性MIのリスクが高くなります.
- sCD40LとcTnIの併用評価は,ACS患者の死亡とMIに関する補完的な予後情報を提供します.
さらに関連する動画
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
2.1K
09:09Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
221
関連する概念動画
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
943
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495